Methods for Upregulating Immune Responses Using Combinations of Anti-RGMb and Anti-Pd-1 Agents
Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- DANA-FARBER CANCER INSTITUTE, INC., Boston, Massachusetts has been assigned a patent (No. US 12139535 B2, initially filed Aug. 23, 2021) developed by Gordon J. Freeman, Brookline, Massachusetts, and Yanping Xiao, Brookline, Massachusetts, for "Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents." . . .